Psychedelics
Mental Health Benefits of Ayahuasca Ceremonies May Be Due to a Placebo Effect, Study Finds
Participants in ayahuasca ceremonies report reductions in stress, anxiety, and depression whether they are given ayahuasca or not, a placebo-controlled study from researchers at Maastricht University has found.
Single Dose of Psychedelic Triggers Long-Lasting Changes in Mouse Brain Connectivity
These epigenetic changes may help to explain the long-lasting improvements to mental health identified in other recent psychedelic research projects.
More People Are Microdosing Psychedelics, World Drug Survey Finds
Around the world, it seems people are microdosing psychedelics more, and consuming other drugs like cocaine, alcohol, and cannabis less.
An Introduction to Five Psychedelics: Psilocybin, DMT, LSD, MDMA and Ketamine
This article from Technology Networks breaks down the qualities of the key five psychedelics and the current research projects illuminating their clinical potential.
Synthetic Psilocybin Shows Promise in Phase 2 Trial For Treatment-Resistant Depression
The trial, which included results from 233 patients across 10 countries, is the largest ever randomized, controlled, double-blind psilocybin therapy study ever completed.
New Rat Study May Explain How LSD Triggers Hallucinations
Under the influence of LSD, the rats ran less and displayed less neuronal activity in their hippocampi.
Detroit Votes to Decriminalize Psilocybin and Other Psychedelics
Under the new measure, “the personal possession and therapeutic use of Entheogenic Plants by adults” with become “the city’s lowest law-enforcement priority.”
“I’ve Never Seen Anything as Effective”: Exploring the Combination of Psychedelics and Psychotherapy
“Ketamine is helpful as a medicine, but there’s so much more to be gained by adding the psychotherapy component,” says Dr Reid Robison, Novamind’s chief medical officer.
Taking a Chemistry-Led, Patient-Centric Approach to Psychedelic Medicine
Led by experienced natural products chemists, Psilera Bioscience is on a mission to create new, next-generation psychedelic medicines that can better serve patients’ needs.
Medicinal Genomics Publishes Genome of Psilocybe Cubensis
Scientists at Medicinal Genomics have published a peer-reviewed, highly-contiguous reference genome for the psychedelic mushroom species Psilocybe cubensis.
